Oxytocin

Research-Grade

Oxytocin is a cyclic nonapeptide (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂) synthesized in the paraventricular and supraoptic nuclei of the hypothalamus and released from the posterior pituitary. It is one of the most thoroughly studied peptide hormones in medicine. Its classical functions — uterine contraction during labor and milk ejection during breastfeeding — led to FDA approval of synthetic oxytocin (Pitocin) for labor induction and postpartum hemorrhage. These remain its primary clinical applications. The modern research interest in oxytocin centers on its role in social cognition and behavior. Intranasal oxytocin administration has been studied in over 300 clinical trials for conditions including autism spectrum disorder (ASD), social anxiety disorder, PTSD, schizophrenia, and borderline personality disorder. Results have been mixed: early single-dose studies showed enhanced social attention, empathy, and trust, but larger RCTs have generally failed to show clinically meaningful long-term behavioral changes. The disconnect between acute laboratory effects and clinical efficacy has led to a more nuanced understanding. Oxytocin appears to modulate social salience rather than simply 'increasing trust' — it can enhance both prosocial and antisocial responses depending on context. Individual differences in endogenous oxytocin system tone, receptor polymorphisms, and attachment history influence response to exogenous administration.